Armistice Capital »

180 Life Sciences Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of 180 Life Sciences Corp shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in 180 Life Sciences Corp

Tip: Access up to 7 years of quarterly data

All positions including 180 Life Sciences Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 180 Life Sciences Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $80k 131k 0.61

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Supernus Pharmaceuticals (SUPN)
Argenx Se Sponsored Adr (ARGX)
Deciphera Pharmaceuticals (DCPH)
Agios Pharmaceuticals (AGIO)
Immunovant (IMVT)
Sanofi Sponsored Adr (SNY)
Aurinia Pharmaceuticals (AUPH)
Dentsply Sirona (XRAY)
Travere Therapeutics (TVTX)

View all positions for Armistice Capital